243 related articles for article (PubMed ID: 29980582)
1. Foxp3
Stockenhuber K; Hegazy AN; West NR; Ilott NE; Stockenhuber A; Bullers SJ; Thornton EE; Arnold IC; Tucci A; Waldmann H; Ogg GS; Powrie F
J Exp Med; 2018 Aug; 215(8):1987-1998. PubMed ID: 29980582
[TBL] [Abstract][Full Text] [Related]
2. IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation.
Gharaee-Kermani M; Estadt SN; Tsoi LC; Wolf-Fortune SJ; Liu J; Xing X; Theros J; Reed TJ; Lowe L; Gruszka D; Ward NL; Gudjonsson JE; Kahlenberg JM
J Invest Dermatol; 2022 Jan; 142(1):155-165.e3. PubMed ID: 34364883
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation.
Hartwig T; Zwicky P; Schreiner B; Yawalkar N; Cheng P; Navarini A; Dummer R; Flatz L; Conrad C; Schlapbach C; Becher B
Cell Rep; 2018 Dec; 25(13):3564-3572.e4. PubMed ID: 30590032
[TBL] [Abstract][Full Text] [Related]
4. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis.
Bovenschen HJ; van Vlijmen-Willems IM; van de Kerkhof PC; van Erp PE
Dermatology; 2006; 213(2):111-7. PubMed ID: 16902287
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
Hansen W; Hutzler M; Abel S; Alter C; Stockmann C; Kliche S; Albert J; Sparwasser T; Sakaguchi S; Westendorf AM; Schadendorf D; Buer J; Helfrich I
J Exp Med; 2012 Oct; 209(11):2001-16. PubMed ID: 23045606
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.
Buchwald ZS; Kiesel JR; DiPaolo R; Pagadala MS; Aurora R
PLoS One; 2012; 7(6):e38199. PubMed ID: 22701612
[TBL] [Abstract][Full Text] [Related]
8. Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4
Chen Y; Zhang Q; Liu H; Lu C; Liang CL; Qiu F; Han L; Dai Z
Front Immunol; 2018; 9():2092. PubMed ID: 30258447
[TBL] [Abstract][Full Text] [Related]
9. Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis.
Leijten EF; van Kempen TS; Olde Nordkamp MA; Pouw JN; Kleinrensink NJ; Vincken NL; Mertens J; Balak DMW; Verhagen FH; Hartgring SA; Lubberts E; Tekstra J; Pandit A; Radstake TR; Boes M
Arthritis Rheumatol; 2021 Jul; 73(7):1220-1232. PubMed ID: 33452865
[TBL] [Abstract][Full Text] [Related]
10. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.
Sather BD; Treuting P; Perdue N; Miazgowicz M; Fontenot JD; Rudensky AY; Campbell DJ
J Exp Med; 2007 Jun; 204(6):1335-47. PubMed ID: 17548521
[TBL] [Abstract][Full Text] [Related]
11. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
[TBL] [Abstract][Full Text] [Related]
12. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
Lo Re S; Lecocq M; Uwambayinema F; Yakoub Y; Delos M; Demoulin JB; Lucas S; Sparwasser T; Renauld JC; Lison D; Huaux F
Am J Respir Crit Care Med; 2011 Dec; 184(11):1270-81. PubMed ID: 21868503
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.
Liu Y; Wang L; Predina J; Han R; Beier UH; Wang LC; Kapoor V; Bhatti TR; Akimova T; Singhal S; Brindle PK; Cole PA; Albelda SM; Hancock WW
Nat Med; 2013 Sep; 19(9):1173-7. PubMed ID: 23955711
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Expansion of Endogenous Regulatory T Cell Populations Induces Long-Term Suppression of Contact Hypersensitivity.
El Beidaq A; Link CW; Hofmann K; Frehse B; Hartmann K; Bieber K; Martin SF; Ludwig RJ; Manz RA
J Immunol; 2016 Sep; 197(5):1567-76. PubMed ID: 27439515
[TBL] [Abstract][Full Text] [Related]
19. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
Fulton RB; Meyerholz DK; Varga SM
J Immunol; 2010 Aug; 185(4):2382-92. PubMed ID: 20639494
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
Liu T; Soong L; Liu G; König R; Chopra AK
Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
